179 related articles for article (PubMed ID: 10740143)
1. Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study.
Echemann M; Zannad F; Briançon S; Juillière Y; Mertès PM; Virion JM; Villemot JP
Am Heart J; 2000 Apr; 139(4):624-31. PubMed ID: 10740143
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study).
Echemann M; Alla F; Briançon S; Juillière Y; Virion JM; Mertès PM; Villemot JP; Zannad F; Aliot E; Breton Ch; KhalifE K; Neimann JL; Allam S; Admant P; Baille N; Bellanger P; D'Hôtel R; Dambrine P; Dodet JF; Graille M; Kessler M; Rebeix G; Royer ; Saulnier JP; Thisse JY; Trutt B; Vidal P; Vuillemin MCh; Delahaye ; Ducimetière P; Fagnani F; Guize L;
Eur J Heart Fail; 2002 Oct; 4(5):647-54. PubMed ID: 12413509
[TBL] [Abstract][Full Text] [Related]
3. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
[TBL] [Abstract][Full Text] [Related]
4. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with heart failure and left ventricular systolic dysfunction.
Rangaswamy C; Finn JI; Koelling TM
Cardiology; 2005; 103(1):17-23. PubMed ID: 15528896
[TBL] [Abstract][Full Text] [Related]
6. Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting.
Philbin EF
Clin Cardiol; 1998 Feb; 21(2):103-8. PubMed ID: 9491949
[TBL] [Abstract][Full Text] [Related]
7. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
[TBL] [Abstract][Full Text] [Related]
8. Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE).
Al-Zakwani I; Sulaiman K; Al-Lawati JA; Alsheikh-Ali AA; Panduranga P; Al-Habib KF; Al Suwaidi J; Al-Mahmeed W; Al-Faleh H; Elasfar A; Al-Motarreb A; Ridha M; Bulbanat B; Al-Jarallah M; Bazargani N; Asaad N; Amin H
Curr Vasc Pharmacol; 2018; 16(6):596-602. PubMed ID: 28820057
[TBL] [Abstract][Full Text] [Related]
9. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.
Philbin EF; Rocco TA; Lindenmuth NW; Ulrich K; Jenkins PL
Am J Med; 2000 Dec; 109(8):605-13. PubMed ID: 11099679
[TBL] [Abstract][Full Text] [Related]
10. Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure.
McDermott MM; Lee P; Mehta S; Gheorghiade M
Clin Cardiol; 1998 Apr; 21(4):261-8. PubMed ID: 9562936
[TBL] [Abstract][Full Text] [Related]
11. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
[TBL] [Abstract][Full Text] [Related]
12. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidémiologie de l'Insuffisance Cardiaque Avancée en Lorraine.
Zannad F; Briancon S; Juilliere Y; Mertes PM; Villemot JP; Alla F; Virion JM
J Am Coll Cardiol; 1999 Mar; 33(3):734-42. PubMed ID: 10080475
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the use of angiotensin-converting enzyme inhibitors for older nursing home residents with chronic heart failure.
Forman DE; Chander RB; Lapane KL; Shah P; Stoukides J
J Am Geriatr Soc; 1998 Dec; 46(12):1550-4. PubMed ID: 9848817
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.
Granger CB; Ertl G; Kuch J; Maggioni AP; McMurray J; Rouleau JL; Stevenson LW; Swedberg K; Young J; Yusuf S; Califf RM; Bart BA; Held P; Michelson EL; Sellers MA; Ohlin G; Sparapani R; Pfeffer MA
Am Heart J; 2000 Apr; 139(4):609-17. PubMed ID: 10740141
[TBL] [Abstract][Full Text] [Related]
15. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.
Johnson D; Jin Y; Quan H; Cujec B
J Am Coll Cardiol; 2003 Oct; 42(8):1438-45. PubMed ID: 14563589
[TBL] [Abstract][Full Text] [Related]
16. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
Fröhlich H; Nelges C; Täger T; Schwenger V; Cebola R; Schnorbach J; Goode KM; Kazmi S; Katus HA; Cleland JG; Clark AL; Frankenstein L
Am Heart J; 2016 Aug; 178():28-36. PubMed ID: 27502849
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
Aronow WS
J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
[TBL] [Abstract][Full Text] [Related]
18. Quality of congestive heart failure treatment at a Canadian teaching hospital.
Weil E; Tu JV
CMAJ; 2001 Aug; 165(3):284-7. PubMed ID: 11517643
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure.
Chen YT; Wang Y; Radford MJ; Krumholz HM
Am Heart J; 2001 Mar; 141(3):410-7. PubMed ID: 11231438
[TBL] [Abstract][Full Text] [Related]
20. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Granger CB; McMurray JJ; Yusuf S; Held P; Michelson EL; Olofsson B; Ostergren J; Pfeffer MA; Swedberg K;
Lancet; 2003 Sep; 362(9386):772-6. PubMed ID: 13678870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]